GlassScriptPhysician profile
Ali Ahmad
NPI 1437736865
$1,749.05
in general payments reported to CMS, 2019-2025
11 companies · $1,749 in 2025
The $1,749 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,512 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.88 |
| Education | $237.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $611.36 | 2025 | Ensite, Perclose Prostyle, Dragonfly Opstar |
| Amgen INC. | $262.51 | 2025 | Repatha, Repatha |
| Angiodynamics, INC. | $183.03 | 2025 | Alphavac |
| Cardiva Medical, INC. | $154.09 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Lilly USA, LLC | $121.84 | 2025 | |
| Chiesi USA, INC. | $110.17 | 2025 | Kengreal |
| Cvrx, INC. | $103.57 | 2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $103.00 | 2025 | Attruby |
| Medical Device Business Services, INC. | $42.75 | 2025 | Vistaseal |
| Abiomed | $30.26 | 2025 | |
| Lantheus Medical Imaging, INC. | $26.47 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.